Adenoviral conjunctivitis is a common condition that is aggressively contagious, and therefore, requires early diagnosis. Often the best course of action is to let the infection run its course; however, some possible treatments are currently being investigated. One of these is a combination of dexamethasone and povidone-iodine, which is hoped will remove the infection quicker and reduce inflammation. The other experimental treatment is brincidofovir, which has shown efficacy in systemic adenoviral infection, though not specifically in the eye. In an expert interview filmed at AAO 2018, editorial board member Dr Bennie Jeng discusses the complications and potential treatment options for adenoviral conjunctivitis. He explains that while treatment with corticosteroids is not ideal, and something he tries to avoid, it can sometimes be necessary for highly symptomatic patients or those with subepithelial infiltrates which could result in scarring. Infiltrates can be very responsive to steroids; however, they may reoccur many times, leaving the patient reliant on steroids for an extended time. Dr Jeng explains how to manage these patients and the best methods for tapering patients off steroids.
1. What are the common clinical presentations of adenoviral conjunctivitis? (0:11)
2. What are the consequences of delayed diagnosis of adenoviral conjunctivitis? (0:32)
3. What are the most effective ways of managing the condition? (1:12)
4. What is your opinion on the use of corticosteroids for the treatment of subepithelial infiltrates? (3:17)
Speaker disclosures: Bennie Jeng has nothing to disclose in relation to this interview.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.
Share this Video
Related Videos In Corneal Disorders
Ana Mercedes García-Albisua, ASCRS 2022: Bowman Layer Transplantation Using a Femtosecond Laser for Keratoconus
Keratoconus is characterized by the thinning of the cornea and irregularities of the cornea’s surface. In this touchOPHTHALMOLOGY interview with Dr Ana Mercedes García-Albisua (Hospital “Luis Sánchez Bulnes”, México City, México), a variation of the original manual Bowman layer transplantation technique is described. After the isolation of the graft, a stromal pocket is created using […]
Ana Mercedes García-Albisua, ASCRS 2022: Bowman Layer Transplantation Using a Femtosecond Laser: 3 Years Results
The aims, design and findings of the retrospective study evaluating the 3-year clinical outcomes of isolated Bowman layer transplantation using femtosecond laser as a treatment for patients with progressive keratoconus is discussed in this touchOPHTHALMOLOGY interview with Dr Ana Mercedes García-Albisua (Hospital “Luis Sánchez Bulnes”, México City, México) as well as how possible complications of […]
Paula Sepulveda-Beltran, ASCRS 2022: Clinical and Surgical Outcomes of Keratoplasty in Individuals That Received Rose Bengal Photodynamic Antimicrobial Therapy
The long-term clinical outcomes of Rose Bengal Photodynamic Antimicrobial Therapy (RB-PDAT) for infectious keratitis and the surgical outcomes of individuals that underwent keratoplasty after RB-PDAT is discussed in this touchOPHTHALMOLOGY interview with Dr Paula Sepulveda-Beltran (Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL). RB-PDAT is a potential adjunct therapy for infectious […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!